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Abstract
 .Like neutrophils, Epstein–Barr virus EBV -immortalized B lymphocytes express all constituents of the NADPH oxidase
complex necessary to generate superoxide anion Oy. The NADPH oxidase activity in EBV-B lymphocytes is only 5% of2
that measured in neutrophils upon PMA stimulation. Cytochrome b is the sole redox membrane component of NADPH558
oxidase; it is the protein core around which cytosolic factors assemble in order to mediate oxidase activity. In the present
study, we have compared the structural and functional properties of cytochrome b from EBV-B lymphocytes and558
neutrophils. Cytochrome b from EBV-B lymphocyte plasma membrane, like that from neutrophils, is characterized by a558
heterodimeric structure with a highly glycosylated b subunit, known as gp91-phox. While the amount of cytochrome b558
 10 .recovered after purification from EBV-B lymphocytes ;0.24 nmol from 10 cells was low compared to that recovered
 .from neutrophils ;10 nmol , the biochemical properties of purified cytochrome b from both EBV-B lymphocytes and558
neutrophils were quite similar with respect to their differential spectra, redox potential, and FAD binding site. Once
cytochrome b was extracted from the EBV-B lymphocyte membrane, it was able to mediate, in a reconstituted system of558
Oy production the same oxidase turnover as that found for cytochrome b extracted from neutrophils. A comparison2 558
between membrane bound and soluble cytochrome b suggested that the weak oxidase activity measured in intact EBV-B558
cells might be the result not only of the small amount of expressed cytochrome b , but also of a defect of the activation558
process in lymphocyte membrane. q 1998 Elsevier Science B.V.
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1. Introduction
The NADPH oxidase of phagocytes is known to be
expressed in Epstein–Barr virus-transformed B lym-
w xphocytes 1,2 . It is a multicomponent membrane-
bound enzyme that catalyzes the one-electron reduc-
y w xtion of oxygen to O at the expense of NADPH 3 .2
In resting cells, the enzyme is not active but acquires
catalytic activity after exposure to appropriate stimuli
w x4–7 . In its active form, NADPH oxidase consists of
a redox membrane component and three cytosolic
factors, p47-phox, p67-phox and p40-phox, for which
translocation to the membrane is critical for NADPH
oxidase activation; moreover, Ras-related G-proteins
such as Rac1 andror Rac2 and Rap1A have been
reported to be implicated in the activation mechanism
w x8,9 . Cytochrome b is the sole membrane redox558
component of NADPH oxidase, whereas the role of
cytosolic factors p47-phox and p67-phox appears to
be restricted to complexing with it, thus converting
cytochrome b into its redox-active state by an as558
w xyet uncharacterized ‘allosteric’ effect 2 . Cy-
tochrome b is a low midpoint potential het-558
w xerodimeric 10,11 transmembrane flavoprotein com-
posed of two polypeptides, a glycosylated heavy
 . w xchain of 91 kDa gp91-phox 12 and a light nongly-
 . w xcosylated polypeptide of 22 kDa p22-phox 13 .
Cytochrome b has been purified from human558
w x w x w x14,15 bovine 16 , porcine 17 and rabbit neu-
w x w xtrophils 18 and from guinea pig macrophages 19 .
The heme b content of neutrophil purified cy-
tochrome b ranges between 20 and 30 nmolrmg558
w xprotein 20 and a ratio of two heme b per het-
w xerodimeric cytochrome b has been postulated 3 .558
The presence of the phagocyte Oy generating2
w xNADPH oxidase in B cells is well established 1,2
but the question of its physiological significance is
unsettled and the B cell NADPH oxidase remains an
enzyme in search of a function. In these cells the
NADPH oxidase could subserve a function different
from the microbicidal activity served in professional
phagocytes; for instance, oxidants generated at low
w xlevel could act as signaling molecules 2 . Studies
with B cells have shown that the oxidase activity of
 .intact cells is very low 5% compared to that of
w xneutrophils 21,22 . Whereas B lymphocyte NADPH
oxidase and neutrophil NADPH oxidase appear to be
similar in their catalytic mechanisms and their molec-
w xular composition 23,24 , they may differ by their
w xactivation mechanism 25 . In order to address the
basis of the low level of oxidase activity in EBV-B
lymphocytes we have partially purified cytochrome
b from EBV-B lymphocytes and explored its bio-558
chemical properties, comparing purified cytochrome
b and membrane-bound cytochrome b from558 558
EBV-B lymphocytes and neutrophils.
2. Experimental procedures
2.1. Materials
Reagents used in this work were obtained from the
 .following sources: diisopropyl fluorophosphate DFP
 .Acros Organics, NJ, USA ; cytochalasin B, phorbol
 .myristate acetate PMA , Na-p-tosyl-L-lysine
 . chloromethyl ketone TLCK , leupeptin hemisulfate
.salt, from microbial source , L-a-phosphatidylcholine
 . type II-S , L-a-phosphatidic acid from egg yolk
. lecithin , phenosafranin Sigma Chemical, St. Louis,
.MO, USA ; sucrose monolaurate, endoglycosidase
FrN-glycosidase F, phenylmethylsulfonyl fluoride
 . PMSF , pepstatin, n-octylglucoside Boehringer
.Mannheim, Meylan, France ; Sephacryl S-300 HR,
DEAE Sepharose CL-6B, CM Sepharose CL-6B,
octyl Sepharose CL-4B, protein A-Sepharose CL-4B
 .Pharmacia LKB, Biotechnology, Uppsala, Sweden ;
Heparin-Ultrogel A 4 R Sepracor IBF Biotechnics,
. France ; Carbolinke coupling gel Pierce, Rockford,
.IL, USA ; ECL Western blotting detection reagents
 .Amersham, Buckinghamshire, UK . Monoclonal an-
tibodies mAb 48 and mAb 449 were a generous gift
from Dr. D. Roos and Dr. A. Verhoeven. Recombi-
nant Rac-1 was kindly provided by M.C. Dagher and
J. Faure.´
2.2. Methods
2.2.1. Lymphoid cell line and neutrophils
Lymphocytes from heparinized sterile venous
blood were prepared by Ficoll–Hypaque density gra-
dient centrifugation. The cells were infected with the
B95-8 strain of the Epstein–Barr virus. The
 .Epstein–Barr virus transformed B EBV-B cell line
was kept in RPMI-1640 medium supplemented with
10% foetal calf serum, 100 Urml penicillin, 50
mgrml kanamycin and 100 mgrml streptomycin.
The cells were maintained at 378C in a 5% CO2
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w xatmosphere 22 . The medium was changed twice
weekly.
Neutrophils were isolated from human blood and
w xstored overnight at 4–108C, as described in Ref. 26 .
Cytosolic and crude membrane fractions from both
w xcell types were prepared as reported previously 27 .
2.2.2. Purification of cytochrome b from neu-558
trophils
Cytochrome b was purified from the plasma558
membranes of 1010 phorbol ester-stimulated neu-
w xtrophils, as reported previously 28 . All steps of the
purification procedure were carried out at 48C, and
the different buffers contained the following protease
inhibitor mixture: 10 mM Na-p-tosyl-L-lysine
chloromethyl ketone, 1 mM phenylmethylsulfonyl
fluoride, 1.8 mM leupeptin and 1.5 mM pepstatin.
 8Briefly, 3 mM DFP-treated neutrophils 10
cellsrml in PBS supplemented with 0.9 mM CaCl ,2
.0.5 mM MgCl were preincubated for 15 min at2
378C with 5 mM cytochalasin B before addition of
PMA at a concentration of 0.5 mgr108 cells, for 10
min. PMA-activated neutrophils were sonicated, and
the postnuclear supernatant was centrifuged at
200 000=g for 60 min, at 48C. The resulting mem-
brane pellet, after washing with 1 M NaCl, was
resuspended in 100 mM Hepes pH 7.2, containing
100 mM KCl, 10 mM NaCl, 1 mM EDTA, 0.1 mM
 .dithiothreitol, 20% vrv glycerol and the antipro-
 .tease mixture buffer A . Cytochrome b was solu-558
 .bilized with 2% wrv n-octyl glucoside and the
200 000=g detergent extract was passed through a
mixed bed of CM-Sepharose, DEAE-Sepharose, N-
amino octyl-Sepharose. The cytochrome b was558
then bound to a Heparin-Ultrogel column as de-
w xscribed 14,28 , using buffer A supplemented with
 .  .0.1% wrv Triton X-100 buffer B to equilibrate
the column. Bound cytochrome b was eluted with558
a linear 0.04–1.50 M NaCl gradient. The cytochrome
b -enriched eluates were pooled and applied to a558
Sephacryl S-300 column equilibrated in buffer B.
After filtration, the heme-containing fractions were
pooled and stored at y808C, until further use. Cy-
tochrome b was quantitated by reduced minus558
oxidized difference spectroscopy using an absorption
coefficient of 106 mMy1 cmy1 for the Soret band at
426 nm. The identity of purified cytochrome b558
was assessed immunochemically, using a neutrophil
cytochrome b deficient CGD mutant as negative558
w xcontrol 28 .
2.2.3. Preparation of EBV-B lymphocyte plasma
membranes
 10 .EBV-B lymphocytes 2=10 cells were col-
lected after three washing steps in PBS and then
treated with 3 mM DFP.The lymphocytes were resus-
pended at a concentration of 108 cellsrml in PBS
supplemented with the antiprotease mixture and soni-
cated for 2=10 s at 40 W, using a Branson sonifier.
The cell homogenate was centrifuged at 1000=g for
 .10 min. The postnuclear supernatant 3.5 ml was
overlaid on a discontinuous sucrose gradient compris-
 .ing two 4-ml sucrose layers of 35% wrv and 15%
 .wrv respectively, in PBS supplemented with 1 mM
EDTA. Centrifugation was carried out using a SW 41
rotor at 150 000=g for 75 min. The plasma mem-
brane-enriched fraction located at the interface be-
tween the two sucrose layers was collected by aspira-
tion with a Pasteur pipette, and diluted 3-fold in PBS
containing the protease inhibitor mixture. The mem-
branes were sedimented at 100 000=g for 45 min,
and resuspended in buffer A at a protein concentra-
tion of 2–3 mgrml. All steps were carried out at
q48C.
2.2.4. Detergent solubilization and purification of
phagocyte cytochrome b from EBV-B lymphocytes558
EBV-B lymphocyte membranes suspended in
 .buffer A 2–3 mgrml were supplemented with 1%
 .  .wrv sucrose monolaurate final concentration , and
stirred gently for 20 min at 48C. Following extrac-
tion, the mixture was centrifuged at 200 000=g for
60 min and the 1% sucrose monolaurate supernatant
was collected and diluted twofold in buffer B. The
diluted extract was submitted to two successive chro-
w xmatographic steps 28 on DEAE-Sepharose and Hep-
arin-Ultrogel; each matrix was equilibrated with
buffer B. The detergent was changed from sucrose
w xmonolaurate to Triton X-100, as suggested 20 , to
increase the overall yield of cytochrome b during558
purification. The hemoprotein in column effluents
was monitored by measuring dithionite-reduced mi-
nus oxidized difference absorbance of the a peak at
558 nm.
Following 1 h of batch adsorption on DEAE-Sep-
 .harose 20 ml bed volume the unbound fraction was
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loaded onto an 8-ml-column of Heparin-Ultrogel. The
matrix was extensively washed in buffer B, and
bound cytochrome b was eluted with 20 ml of a558
 .0–1.5 M linear NaCl gradient flow rate of 20 mlrh .
The cytochrome b -containing fractions were pooled558
and applied to a Sephacryl S-300 column 1=100
.cm equilibrated in the same buffer. Elution was
performed with buffer B at a flow rate of 5 mlrh.
Cytochrome b containing fractions were collected558
and cytochrome b was immediately relipidated558
and concentrated on a Centriprep 30 column to a
final concentration of 0.2–0.5 nmolrml, to be stored
at y808C until further use. Throughout purification,
the identity of cytochrome b in each pooled frac-558
tion was assessed with specific monoclonal antibod-
ies, and after purification, it was quantified spec-
trophotometrically as described previously for neu-
trophil cytochrome b .558
2.2.5. Relipidation of purified cytochrome b558
Prior to relipidation of cytochrome b , Triton558
X-100 was replaced with 40 mM n-octyl glucoside,
w xas described previously 28 . Relipidation was per-
formed in the presence of L-a-phosphatidylcholine II
 .S and L-a-phosphatidic acid 1:1 , which were sus-
pended at a final concentration of 1 mgrml in 120
mM NaH PO buffer, pH 7.2, containing 1 mM2 4
 .MgCl , 1 mM dithiothreitol, 20% vrv glycerol, 12
mM EGTA, 40 mM n-octyl glucoside and the usual
 .antiprotease mixture. Phospholipids 100 mg were
mixed with approximately 400 pmol of purified cy-
tochrome b . The mixture was diluted sixfold with558
the latter buffer without detergent, and was either
incubated for 30 min on ice, prior to testing oxidase
activity in the cell-free assay, or stored at y808C
w x19,29 .
2.2.6. Isolation of the p47-phoxrp67-phoxrp40-
phox complex
Polypeptide corresponding to the COOH-terminal
 .region of p47-phox residues 371 to 390 was synthe-
 .sized by Neosystem Strasbourg, France . Antisera
against the synthetic polypeptide was raised in rabbits
by repeated injections of the keyhole limpet hemo-
cyanin conjugate and was submitted to Ig purification
on 1 ml of protein A-Sepharose CL-4B matrix. Anti-
p47-phox Igs were immobilized on Carbolinke cou-
pling gel through their oxidized carbohydrate moiety
according to the manufacture’s instructions. Cytosol
from EBV-B lymphocytes 50 to 100 mg, or 2–5=
9 .10 cell equivalents was loaded onto the Carbolink
matrix, equilibrated in PBS, with recycling overnight
at q48C. After washing in PBS the bound proteins
were eluted with 0.1 M glycine pH 2.5. Eluates were
immediately neutralized with 1 M Tris–HCl, pH 9.5,
pooled and dialyzed against PBS. The respective ratio
of the factors in the complex was estimated to be 1.4;
1.1; 1.0 for p67-phox, p47-phox and p40-phox re-
 .spectively not shown .
2.2.7. Cell-free system of NADPH oxidase acti˝ation
NADPH oxidase activation in a heterologous or
homologous cell free system has been described pre-
w xviously 22 . The medium for oxidase activation con-
tained 30 mg protein of crude membrane, 300 mg of
cytosol protein obtained from resting cells, 40 mM
w xGTP S , 5 mM MgCl , and arachidonic acid, in a2
final volume of 100 ml. A preliminary assay was
performed to determine the optimal amount of arachi-
donic acid to be added to provide maximal oxidase
activation. The oxidase activation medium was incu-
bated for 10 min at 258C, and was then transferred to
a photometric cuvette for measurement of the rate of
formation of the superoxide anion. Reconstituted oxi-
dase activity was assessed by measuring the rate of
superoxide sensitive cytochrome c reduction at 550
 .nm. The absorption coefficient « for reduced cy-
tochrome c at 550 nm was 21.1 mMy1 cmy1. In
some experiments, the cytosol of EBV-B lympho-
cytes was replaced with 10 mg of the p47-
phoxrp67-phoxrp40-phox complex isolated on a
Carbolinke affinity matrix and reconstitution experi-
ments were carried out either with sucrose monolau-
 .rate soluble extract 0.5 to 2 mg or with a cy-
 .tochrome b -enriched fraction 0.1 to 0.5 pmol558
instead of crude membranes. In the latter case, puri-
fied cytochrome b was relipidated and 10 mM558
FAD was added to the medium.
2.2.8. Oxido–reduction potential measurements
The midpoint oxido–reduction potential of puri-
fied cytochrome b from human neutrophils and558
EBV-B lymphocytes was determined using
w xphenosafranin dye as redox potential indicator 30 .
The sample cuvette contained purified cytochrome
 .b 0.1–0.5 mM in buffer B and phenosafranin558
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 .0.2–2 mM ; the solution was made anaerobic with
nitrogen. The sample cuvette was stoppered with a
ribbon plug bearing three needles. One needle was
used for continuous flushing with oxygen-free nitro-
gen, the second one served as the outlet for nitrogen
and the third one was used for the various additions.
During the redox titration, the solution was stirred by
a spiral-stirring bar driven by a motor placed above
the sample cuvette. Spectra were recorded at room
temperature, using a DU 640 Beckman spectro-
photometer. After a few minutes equilibration with
nitrogen, the reference spectrum was recorded before
any addition was made to the sample cuvette. Reduc-
tive titration was then carried out by subsequent
additions of small amounts of sodium dithionite.
Spectra were recorded after each addition. The reduc-
tion of cytochrome b was monitored as measure-558
 .ment of the increase in its Soret peak 426 nm , and
the reduction of phenosafranin was shown as a pro-
gressive increase of absorbance at 523 nm. When the
spectra showed that cytochrome b reduction had558
reached its maximum, the oxidative titration was
performed by adding small amounts of air to the
sample cuvette and following the decrease in the
cytochrome b peak and the increase in the558
phenosafranin peak. Cytochrome b potential was558
then calculated by plotting the log of the ratio of the
oxidized to the reduced cytochrome vs. the potential
of the solution; it was calculated from the Nernst
equation using a value of ns2 and a midpoint
potential for phenosafranin of y252 mV.
[ [ (2.2.9. Synthesis of titrated 4- N- 4-azido-2-
) ] ] [ 3 ]nitrophenyl amino butyryl FAD, H NAP -FAD4
The arylazidocarboxylic acid, 4- N-4-azido-2-
. x w3 xnitrophenyl amino H butyric acid referred to as
w3 xH NAP , was synthesized and coupled by esterifica-4
tion to the ribose group of FAD, using carbodiimida-
zole as a catalyst of activation of the carboxylic
w xgroup as described 31 .
2.2.10. Co˝alent photolabeling of proteins with
[3 ]H NAP4-FAD
w3 xEfficient and specific binding of H NAP -FAD4
to the flavin sites of EBV-B lymphocyte plasma
membranes required treatment of the membranes with
detergent in saline solution to release endogeneous
flavin. Briefly, a suspension of EBV-B lymphocyte
plasma membranes in PBS 0.5 mg protein in 0.5 ml
. w3 xfinal volume was incubated with 5 mM H NAP -4
FAD, in the presence of 40 mM Tris–HCl, pH 7.5
 .and 0.05% wrv sodium deoxycholate. Incubation
was carried out in the dark for 15 min at 48C. The
membrane suspension was placed in an ice bath
under a 1000-W xenon XBO lamp and photoirradi-
ated for periods of time ranging between 2 and 5 min.
Following the photoirradiation, the membrane sus-
pension was diluted 5 times with PBS and the mem-
branes were collected by centrifugation. Non-specific
binding was assessed in the presence of an excess of
 .unlabeled FAD 50 mM . The membrane bound ra-
dioactivity was measured by liquid scintillation
counting after SDS-PAGE. The Coomassie blue-col-
ored gel was cut into strips, and each strip was cut
into 2-mm slices, in order to localize the radiolabeled
proteins. The slices were bleached by overnight incu-
 .bation at 60–658C with 1 ml of 10% vrv H O .2 2
Excess H O was removed with catalase, and ra-2 2
dioactivity was measured by liquid scintillation
w x w3 xcounting 31 . Specific binding of H NAP -FAD to4
the flavin sites of cytochrome b purified from558
neutrophils was also carried out as control. Briefly, a
 .fraction of purified cytochrome b 200–500 pmol558
w3 xin buffer B was incubated with 1 mM H NAP -FAD4
in the presence of 50 mM Tris–HCl pH 6.2 and 2.5
mM MgCl . Incubation was carried out in the dark2
for 15 min at 48C, then the mixture was photoirradi-
ated under the 1000-W xenon XBO lamp for 2 min.
Following photoirradiation, proteins were precipitated
 .with acetone 90% saturation and collected by cen-
trifugation. Nonspecific binding was assessed in the
presence of an excess of unlabeled FAD, as for
membranes. Protein bound radioactivity was mea-
w xsured as described previously 31 .
2.2.11. Gel electrophoresis
w xSDS-PAGE 32 was carried out using 10% or
12% polyacrylamide resolving gels containing 0.2%
 .wrv SDS and a 5% stacking gel. Proteins were
detected by staining either with Coomassie blue or
w xwith silver nitrate 33 .
2.2.12. Immunoblotting
Following SDS-PAGE, the resolved proteins were
electrotransferred from acrylamide to nitrocellulose
sheets at 100 mA for 16 h at 48C as described in Ref.
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Table 1
Isolation of plasma membrane from EBV-B lymphocyte ho-
mogenate on sucrose gradient
Fractions Cytochrome Concanavalin A-FITC
oxidase fluorescence
 .  .nmolrmin % of total
Cytosol 0 5
Light fraction 42 65
Dense fraction 177 20
Plasma membrane from EBV-B lymphocytes was isolated by
subcellular fractionation.
2=1010 EBV-B lymphocytes treated with DFP were sonicated;
the low speed supernatant was overlaid on a discontinuous
sucrose gradient as described in Section 2. Three fractions were
 .collected and identified by specific markers total activity . The
results are representative of two experiments.
w x34 . The nitrocellulose sheets were first washed for 1
h in 50 mM Tris–HCl, pH 7.5, supplemented with
 .0.1% wrv Tween 20, and then washed three times
 .in the same buffer supplemented with 0.05% wrv
Tween 20. They were then incubated for 1–4 h at
room temperature with specific polyclonal or mono-
clonal antibodies directed against the neutrophil cy-
 .tochrome b a or b subunit . The immune com-558
plexes were detected with goat anti-rabbit or goat
anti-mouse secondary antibodies conjugated to alka-
line phosphatase or peroxidase. The bound phos-
phatase activity was measured by staining with ni-
troblue tetrazolium. The bound peroxidase activity
was detected by using ECL reagents Amersham Life
.Science .
2.2.13. Deglycosylation experiments
N-linked oligosaccharides of glycoproteins were
removed with endoglycosidase FrN-glycosidase F,
w x  .as described in Ref. 35 . Plasma membranes 50 mg
 .or sucrose monolaurate soluble extract 100 mg from
EBV-B lymphocytes or neutrophils diluted in PBS 1
.mgrml were denatured by heating for 2 min at
 .1008C in the presence of 0.2% wrv SDS and 1%
 .wrv b-mercaptoethanol. After SDS denaturation,
 .2% wrv n-octyl glucoside was added to the dena-
tured sample, before adding N-glycosidase F 2 U for
.100 pmol of cytochrome b . After incubation for 4 h
at 378C, the reaction was stopped by adding one
volume of Laemmli buffer.
2.2.14. Cytochrome b spectroscopy
Absorption spectra were recorded at room temper-
ature with a DU 640 Beckman spectrophotometer.
Reduction in the sample cuvette was achieved with a
few grains of sodium dithionite and dithionite re-
duced minus oxidized difference spectra were
w xrecorded 36 . The amount of reduced flavocy-
tochrome b was determined from the absorbance of
 .the Soret band 426 nm using an « value of 106426
y1 y1 w x  y1mM cm 36 or at 558 nm « s21.3 mM558
y1.cm . The binding of butyl isocyanide to dithionite
reduced cytochrome b was monitored by following
the shift of the Soret peak from 426 nm to 434 nm.
The amount of the reduced heme b–butyl isocyanide
complex was determined from the absorbance at 434
y1 y1 w xnm using an « value of 115 mM cm 37 .434
Fig. 1. Subcellular distribution of cytochrome b in EBV-B558
lymphocytes. 2=1010 EBV-B lymphocytes were sonicated and
the low-speed supernatant was overlaid on a discontinuous den-
 .  .sity gradient comprising two 35% wrv and 15% wrv sucrose
layers. After centrifugation at 150000= g for 75 min, two
fractions were collected, the plasma membrane-enriched fraction
 .at the interface of the layers plain line and a dense fraction as a
 .  .pellet dotted line . A Redox difference spectra of the two
 .fractions B . Immunodetection of cytochrome b in plasma558
membrane-enriched fraction after 10% SDS-PAGE, followed by
electrotransfer onto nitrocellulose, was carried out with mono-
 . clonal antibodies 48 b subunit, lane 2 and 449 a subunit, lane
.1 . The results are representative of two experiments.
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2.2.15. Biochemical assays
Cytochrome oxidase activity was determined as
w xdescribed in Ref. 38 . Lectin labelling of EBV-B
lymphocyte plasma membrane was performed with
w xConcanavalin A-FITC as described in Ref. 39 . Pro-
tein concentration was measured using the Bradford
w x40 or the Pierce and Suelter bicinchoninic acid
w xassays 41 , with bovine serum albumin as standard.
3. Results
3.1. Isolation of cytochrome b from EBV-B lym-558
phocytes
In order to dissociate plasma membrane cy-
tochrome b from the mitochondrial cytochromes, a558
plasma membrane-enriched fraction from EBV-B
Fig. 2. Purification of cytochrome b from EBV-B lymphocytes. 15 mg of membrane proteins solubilized in 1% sucrose monolaurate558
 .  .were applied to a DEAE-Sepharose column A . The flow-through peak 1, black bars , which contained cytochrome b was then558,
 .applied to a Heparin-Ultrogel column B . Cytochrome b enriched fractions collected after elution by a linear NaCl gradient and558
 .  .specifically immunodetected with mAb 48 black bars were loaded onto a Sephacryl S-300 column C . Protein absorbance: 280 nm;
 .heme absorbance: Abs 550–560 nm. C Inset: following 10% SDS-PAGE, protein material corresponding to the major peak eluted from
 .Sephacryl S-300 20 pmol was electrotransferred to nitrocellulose sheets. Track 1 was stained with silver nitrate. In track 2, the protein
 .material was allowed to react with monoclonal antibodies against the a and b subunits of cytochrome b mAb449 and mAb 48 .558
 .  .  .  .Differential absorbance spectra, D , E and F dithionite reduced minus oxidized were recorded at each step of the purification. The
 .  .  .protein material corresponding to the two major peaks peak 1 and peak 2 from DEAE-Sepharose A and Heparin-Ultrogel B and to
 .the major peak from Sephacryl S-300 C were reduced by addition of a few crystals of sodium dithionite.
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lymphocytes was isolated on a discontinuous sucrose
gradient. Measurement of enzymatic markers and
spectral detection of cytochromes showed that the
crude membrane fraction of lymphocytes was con-
taminated with mitochondria. Upon subcellular frac-
tionation, a light fraction enriched in plasma mem-
 .brane was obtained Table 1 . The dense fraction
contained the major part of mitochondria identified
by cytochrome oxidase as a specific marker. The
plasma membrane-enriched fraction showed the pres-
 .ence of the two a and b subunits Fig. 1B and the
three spectral bands at 558 nm, 530 nm, and 427 nm
which are typical of neutrophil cytochrome b Fig.558
.1A . It was not necessary to carry out a similar
membrane purification with neutrophils, since they
contain very few mitochondria, resulting in little or
no contamination.
The procedure for purification of cytochrome b558
from human EBV-B lymphocytes was adapted from
w xthat reported for human neutrophils 28 . We tested
the ability of several detergents to solubilize cy-
 .tochrome b from membranes, namely 2% wrv558
 .  .octyl glucoside, 0.5% wrv Triton X-100, 1% wrv
 .deoxycholate and found 1% wrv sucrose monolau-
rate to be the most efficient, with 70% recovery of
cytochrome b in the solubilized fraction. The558
hemoprotein content of the column effluents was
monitored by measuring dithionite reduced minus
oxidized difference absorbance of the a peak at 558
 .nm cf. Section 2 . The sucrose monolaurate extract
was applied to a column of DEAE-Sepharose. The
column was washed with the equilibrium buffer, and
elution was performed with a NaCl gradient Fig.
.2A . Two distinct peaks of heme-containing protein
were separated; the first one was not bound to the
column, and the second was eluted at concentrations
of 0.60–0.80 M NaCl. The two heme-containing
fractions showed similar reduced minus oxidized dif-
 .ferential spectra Fig. 2D , with the exception that the
second peak contained a minute amount of cy-
 .tochrome oxidase peak at 445 nm . Immunoblotting
experiments performed with specific monoclonal an-
tibodies indicated that the flow-through fraction peak
.  .1 , and not the other peak 2 , contained the phago-
 .cyte cytochrome b not shown . The DEAE-flow-558
 .through fraction peak 1 devoid of cytochrome oxi-
dase was loaded onto a Heparin-Ultrogel column.
The first peak from the Heparin-Ultrogel column
corresponded to the pass-through fraction and con-
tained a b-type cytochrome, as shown spectrometri-
 .cally Fig. 2B and E , but this cytochrome did not
react with monoclonal antibodies raised against the a
or b phagocyte cytochrome b subunits. In con-558
trast, the protein fraction eluted with a 0.55–0.70 M
 .NaCl gradient peak 2 contained the typical oxidase
cytochrome b detected by specific antibodies. This558
fraction was subjected to a gel filtration on a
 .Sephacryl S-300 column Fig. 2C . This allowed the
recovery of 130–211 pmol of cytochrome b from558
2=1010 EBV-B lymphocytes, based on the heme
 .content Table 2 . The reduced minus oxidized differ-
ence spectra of the B lymphocyte purified cy-
 .tochrome b solubilized in Triton X-100 Fig. 2F558
was similar to that determined using purified mem-
Table 2
Partial purification of cytochrome b from EBV-B lymphocytes558
Fractions Proteins Cytochrome b Reconstituted Increase558
 .heme content oxidase activity in oxidase
y y1 y1 .nmol O min mg activity2mgrml mg pmolrmg pmol
membranes 2.48 33.7 113 3808 95 1
soluble extract 1.75 23.8 120 2856 1200 13
DEAErHeparin 0.50 2.2 124 267 nd nd
Sephacryl S300 0.06 0.9 191 178 1500 16
 .Cytochrome b was isolated from EBV-B lymphocyte membranes and extracted with 1% wrv sucrose monolaurate according to the558
described methods. Purified cytochrome b was relipidated for oxidase activity reconstitution with 100 mg L-a-phosphatidyl choline558
w x w xand L-a-phosphatidic acid according to Ref. 28 . Reconstitution was carried out with 300 mg neutrophil cytosol, 40 mM GTP S and 5
mM MgCl and the heterologous cell free assay was performed by adding an optimum concentration of arachidonic acid to the medium2
w x22 . The results are representative of five experiments.
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 .branes Fig. 1 . Two polypeptide bands, a peptide
band at 20–22 kDa and a broad diffuse band in the
region of 60 to 90 kDa were immunochemically
identified as the a and b subunits of phagocyte
 .cytochrome b respectively Fig. 2C, inset . Upon558
treatment of the plasma membrane-enriched fraction
Fig. 3. Butyl isocyanide binding to reduced cytochrome b .558
Butyl isocyanide was used for binding to dithionite-reduced
cytochrome b from EBV-B lymphocyte at two steps of purifi-558
 .cation process. A Incubation of a soluble extract of cytochrome
b in sucrose monolaurate 1.8 mg proteinrml; 15 pmol heme558
.b for 25 min with 20 mM butyl isocyanide. Difference ab-
sorbance spectra, dithionite reduced minus oxidized in the ab-
sence of butyl isocyanide or in its presence were recorded at
228C. The trace in the inset corresponds to the difference spec-
 .trum, reduced plus butyl isocyanide minus reduced. B Time
course of butyl isocyanide binding to purified cytochrome b558
 .  .l and membrane bound cytochrome b e . Same experi-558
 .ment as in A . The extent of the reaction of cytochrome b558
with butyl isocyanide was assessed on the basis of the increase in
the band at 434 nm.
Fig. 4. Nernst plot of the redox titration of cytochrome b558
purified from EBV-B lymphocytes and neutrophils. Titration was
performed with purified cytochrome b from EBV-B lympho-558
 .  .  . cytes 0.1 mM plain line or from neutrophils 0.2 mM dotted
.  .line . Phenosafranin 0.2 mM or 0.4 mM respectively was used
as chemical mediator and potential indicator. Titration was car-
ried out with sequential addition of small amounts of sodium
dithionite or oxygen as described in Section 2. The results are
representative of two experiments for EBV-B lymphocyte cy-
tochrome b and five experiments for neutrophil cytochrome558
b .558
and purified cytochrome b from EBV-B lympho-558
cytes with glycosidase, the broad diffuse band of
60–90 kDa was transformed into a unique band of 50
kDa that was immunodetected by monoclonal anti-
bodies raised against the b subunit of cytochrome
 .b not shown . These results indicate that the b558
subunit of cytochrome b from EBV-B lympho-558
cytes is highly glycosylated as previously reported
w xfor cytochrome b from neutrophils 35 . Moreover,558
it was found that after solubilization and purification
of EBV-B lymphocyte cytochrome b , spontaneous558
deglycosylation of the b subunit occurs, with con-
 .comitant increase in proteolysis not shown .
3.2. Biochemical and structural properties of cy-
tochrome b from EBV-B lymphocytes558
3.2.1. Reduced minus oxidized difference spectra
Neutrophil cytochrome b is virtually unreactive558
w xto CO 36 . In contrast butyl isocyanide, another
heme reagent, has been shown to bind to the dithion-
ite-reduced cytochrome b in detergent-solubilized558
w xneutrophil membranes 37,42 . In Fig. 3, we used
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differential spectroscopy to compare the reactivity of
the dithionite reduced heme toward butyl isocyanide
in two cytochrome b -enriched fractions prepared558
from EBV-B lymphocytes, the plasma membrane
fraction in PBS and the purified cytochrome b .558
Treatment of purified cytochrome b in Triton X-558
100 with butyl isocyanide resulted in a shift of the
Soret peak of cytochrome b from 427 nm to 434558
nm and the virtual disappearance of the a and b
 .peaks Fig. 3A . The time course of butyl isocyanide
binding to reduced heme b depended on the ligand
 .concentration not shown , the incubation period and
the purification state of the b-type hemoprotein. The
time course decreased with butyl isocyanide concen-
tration and with the degree of cytochrome b purifica-
tion. In the presence of 20 mM butyl isocyanide,
purified cytochrome b from EBV-B lymphocytes558
 .was totally liganded in 2 min Fig. 3B . Using the
same butyl isocyanide concentration, 80% of the
cytochrome b in a crude sucrose monolaurate ex-558
tract was liganded after 25 min incubation not
.shown . In the case of membrane bound-cytochrome
b only 30% of the hemoprotein was liganded after558
 .20 min incubation Fig. 3B . These results may be
explained either by the contamination of membrane-
Fig. 5. Covalent photolabeling of cytochrome b with558
w3 x  .H NAP -FAD. A Purified cytochrome b from neutrophils4 558
 .500 pmol was incubated for 15 min at 48C in the dark with
w3 x  .H NAP -FAD 1 mM and then photoirradiated for 2 min at4
48C. The photolabeled hemoprotein was subjected to SDS-PAGE
 .as described in the experimental procedure Section 2 . The upper
part of panel A shows the distribution pattern of bound radioac-
tivity in the gel. The black bars correspond to photolabeling in
the presence of 50 mM of unlabeled FAD. The lower panel
shows a Western blot corresponding to immunodetection of the
 .gp91-phox subunit of cytochrome b with mAb 48. B Same558
 .experiment as in A with purified cytochrome b 500 pmol558
from neutrophils after relipidation by L-a-phosphatidylcholine II
 .S and L-a-phosphatidic acid as described in Section 2. C Same
 .experiment as in A with EBV-B lymphocyte plasma mem-
 .branes from a healthy donor 500 mg protein incubated for 15
w3 x  .min at 48C in the dark with H NAP -FAD 5 mM and then4
photoirradiated for 5 min at 48C. The photolabeled membranes
were subjected to SDS-PAGE as described in Section 2.2. The
 .upper part of panel C shows the distribution pattern of bound
 .radioactivity in the gel open bars . The hatched bars correspond
to a parallel experiment in which EBV-B lymphocyte plasma
 .membranes from a CGD X-linked patient 500 mg proteins were
w3 xphotoirradiated with H NAP FAD.4
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Table 3
Reconstitution of NADPH oxidase activity with membrane-bound cytochrome b and a detergent extract of membranes from neutrophil558
and EBV-B lymphocytes
Neutrophils EBV-B lymphocytes
Oxidase activity Oxidase activity
y y1 y y1 y y1 y y1nmol O min mol O s nmol O min mol O s2 2 2 2
y1 y1 y1 y1 .  .  .  .mg protein mol heme b mg protein mol heme b
membranes 1875"205 104"12 96"6 14"1
soluble extract 5036"122 105"3 1245"318 150"39
w xReconstitution was carried out with 300 mg neutrophil cytosol protein, 40 mM GTP S and 5 mM MgCl . Cytochrome b was2 558
 .  .extracted from human neutrophil membranes with 2% wrv octyl-glucoside and from EBV-B lymphocyte membranes with 1% wrv
sucrose monolaurate. Cell free assays were carried out with 30 mg membrane protein or 0.7–1 mg soluble protein in detergent and by
w x  .adding an optimum concentration of arachidonic acid to the medium 22 . The results are representative of five experiments "SD .
bound or detergent-solubilized cytochrome b by558
other b type cytochromes which do not react with
butyl isocyanide, or by the different reactivities of
cytochrome b according to the environment.558
3.2.2. Redox potential determination
A further step in the comparative analysis of neu-
trophil cytochrome b and EBV-B lymphocyte cy-558
tochrome b was the determination of their redox558
 .potentials Fig. 4 . Neutrophil cytochrome b was558
identified as having a low redox potential E sm7
 . w xy245 mV cytochrome b 30,43–45 .y245
Phenosafranin which displays a closely related poten-
 .tial E sy252 mV was used as a redox indicatorm7
w x30 . In our bands, the E value calculated from them7
Nernst equation for neutrophil cytochrome b was558
between y239 mV and y268 mV five experi-
.ments . In the case of EBV-B lymphocyte cy-
tochrome b , the midpoint potential was determined558
as being between y252 mV and y255 mV, a value
similar to that found for neutrophils. For both cell
types, the slope of the Nernst curves was consistent
with cytochrome b functioning as a one-electron558
carrier.
3.2.3. Aryl azido FAD binding site
The redox membrane component of the NADPH
oxidase of the phagocytes has been reported as being
a flavocytochrome b , with a FAD binding site558
w xlocalized on the b subunit 29,31,46,47 . A radiola-
w3 xbeled, photoactive FAD derivative, H NAP -FAD4
was synthesized and used to investigate the FAD
binding site on EBV-B lymphocyte cytochrome b .558
Following SDS-PAGE of photoirradiated membranes,
analysis of the covalently bound radioactivity in the
gel revealed the presence in EBV-B lymphocyte
membranes of a photolabeled protein whose migra-
tion corresponded to that of the immunodetected
gp91-phox. The disappearance of this immunode-
tected protein in B lymphocytes from an X-linked
CGD patient was consistent with the absence of the
 .photolabeled protein Fig. 5C . The specificity of the
photolabeling was insured by the decrease of cova-
lent binding, when 50 mM unlabeled FAD was added
w3 x  .prior to H NAP -FAD not shown . The validity of4
these photolabeling experiments with EBV-B lym-
phocyte membranes was ascertained using parallel
photolabeling assays with purified cytochrome b558
isolated from neutrophils. These experiments Fig.
Table 4
Reconstituted NADPH oxidase activity in homogeneous and
heterogeneous systems
Fractions Reconstituted activity
y y1 y1 .mol O s mol heme b2
Cytochrome b purified from neutrophils558
qneutrophil cytosol 177"21
qEBV-B lymphocyte cytosol 50"7
Cytochrome b purified from EBV-B lymphocytes558
qneutrophil cytosol 187"14
qEBV-B lymphocyte cytosol 59"8
Cell-free activation of NADPH oxidase was performed as re-
ported in Section 2, with purified cytochrome b 0.1 to 0.5558
.  .pmol and cytosol 300 mg protein . The experimental conditions
have been described in Table 2. The turnover values are mean
 .averages " SD from five separate experiments.
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.5A and B showed the presence of a predominant,
broad, radiolabeled band corresponding to the im-
munodetected gp91-phox subunit of cytochrome b .558
Addition of unlabeled FAD prior to incubation with
w3 xH NAP -FAD led to a 50% decrease in bound4
 .radioactivity Fig. 5A which went up to 80–90%
 .after relipidation of cytochrome b Fig. 5B . This558
finding is in agreement with the fact that relipidation
of cytochrome b is required for optimal functional558
activity of the hemoprotein. From these photoaffinity
labeling experiments, it appears that cytochrome b558
from EBV-B lymphocytes as that from human neu-
w xtrophils and bovine neutrophils 28 is a flavocy-
tochrome with a functional FAD prosthetic group
w xlocated on the gp91-phox subunit 31 .
3.3. Function of EBV-B lymphocyte cytochrome b558
as the redox core of the acti˝e NADPH oxidase
The NADPH oxidase activities of membrane-bound
and solubilized cytochrome b from EBV-B lym-558
phocytes were compared after reconstitution in a cell
free system using an optimum amount of arachidonic
acid. The NADPH oxidase in the cell free system was
activated either with crude cytosol or with purified
 .cytosolic factors Sections 2.1 and 2.2 .
As previously reported with intact EBV-B lympho-
w xcytes 27 , the oxidase activity was found to be very
low when reconstituted with membrane-bound cy-
tochrome b . It increased 13-fold after sucrose–558
 .monolaurate extraction Table 3 . With neutrophils
under the same experimental conditions, there was
only a 2.5-fold increase in oxidase activity after
octyl–glucoside extraction of membrane bound cy-
tochrome b , suggesting that in EBV-B lympho-558
cytes, some membrane components may influence the
efficiency of activation. Since Oy as a product of the2
NADPH oxidase activity was measured by cy-
tochrome c reduction, contaminant cytochrome c
 .oxidase present in plasma membranes Table 1 could
have been responsible for the low NADPH oxidase
activity reconstituted with EBV-B lymphocyte plasma
membranes. This was not the case since 0.5 mM
cyanide, which inhibits cytochrome c oxidase, in-
creased reconstituted NADPH oxidase activity by
 .only 15% not shown . At the end of the cytochrome
b purification from EBV-B lymphocytes, the spe-558
cific reconstituted NADPH oxidase activity was in-
creased by 16 fold. The turnover of oxidase was
calculated after we perform reconstitution experi-
ments using an homologous or heterogeneous cell-free
assay. As shown in Table 4, the turnover of the
purified cytochrome b from neutrophils and EBV-558
B lymphocytes is similar and depends on the origin
of the cytosol, namely neutrophil or EBV-B lympho-
cyte cytosol..
Cytosolic activating factors from EBV-B lympho-
cytes isolated as a complex from the affinity matrix
anti p47-phox, were also used instead of crude cy-
tosol to reconstitute oxidase activity upon addition of
purified neutrophil cytochrome b or purified EBV-558
B lymphocyte cytochrome b , and rRac-1. The558
 .measured turnover values Table 5 are similar to
those found after addition of purified neutrophil cy-
tochrome b or purified EBV-B lymphocyte cy-558
Table 5
Turnover of reconstituted NADPH oxidase with the isolated cytosolic factors
y y1Fractions rRac-1 Reconstituted activity mol O s2
y1 .mol heme b
Purified neutrophil cytochrome b558
qEBV-B lymphocyte cytosolic complex 1 mg 67"9
Purified EBV-B lymphocyte cytochrome b558
qEBV-B lymphocyte cytosolic complex 1 mg 53"9
qEBV-B lymphocyte cytosolic complex 4 mg 56"9
 .Cell-free activation of NADPH oxidase was performed as reported in Section 2, using purified cytochrome b 0.1 to 0.5 pmol ,558
p47-phoxrp67-phoxrp40-phox cytosolic factor complex and rRac-1.The experimental conditions of measurement have been described in
 .Table 2. The turnover values are mean averages "SD from four assays.
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tochrome b to crude cytosol from EBV-B lympho-558
 .cytes Table 4 .
4. Discussion
EBV-B lymphocytes have been reported to possess
a NADPH oxidase system able to generate Oy, the2
function of which is unknown in these cells
w x1,2,23,27,48 . The EBV-B lymphocyte oxidase activ-
ity is, however, very low; it is only 5% of that
measured in neutrophils upon PMA stimulation
w x22,48 . It has been postulated that the major limiting
factor of B cell NADPH oxidase activity is the
w xmembrane-bound cytochrome b 26,48 . This study558
was initiated to verify whether B lymphocyte cy-
tochrome b , which is the redox core of NADPH558
oxidase, differs in some chemical or functional prop-
erties from neutrophil cytochrome b , which could558
explain the low NADPH oxidase activity of B cells.
Cytochrome b has been purified from resting558
EBV-B lymphocytes. From the data presented above,
it appears that once purified, the cytochrome b558
from EBV-B lymphocytes behaves similarly to that
 .from neutrophils with respect to 1 spectral proper-
 .  .ties, 2 midpoint redox potential, 3 FAD binding
 . ysite and 4 turnover ability in O production. We2
have shown that cytochrome b from EBV-B lym-558
phocytes, similar to that of neutrophils, is a het-
erodimeric, integral membrane protein comprising a
small subunit p22-phox associated with a large sub-
unit, gp91-phox. Both subunits were detected with
antibodies immunoreactive to neutrophil p22-phox
and gp 91-phox. The widespread presence of gp
91-phox in SDS-PAGE assays could be due to differ-
w xent glycosylation states 15,37 or to a spontaneous
deglycosylation process occurring during the course
 .of purification this study .The midpoint potential of
cytochrome b from B lymphocytes had the same558
value as that of neutrophil cytochrome b , with a558
typical reduced minus oxidized differential spectra
identical to that of cytochrome b from neutrophils558
 .Fig. 2F . In its reduced state, the purified cy-
tochrome b of EBV-B lymphocytes was able to558
react strongly with butyl isocyanide, similarly with
neutrophil cytochrome b , to make a butyl–iso-558
 .cyanide complex Fig. 3B . The butyl–isocyanide
cytochrome b complex is indicative of a function558
of this cytochrome as a terminal oxidase, in spite of
the fact that purified cytochrome b is unable to558
w xreact with cyanide or CO 36 .
Full reconstitution of a functional NADPH oxidase
has been achieved in a heterologous cell free assay,
using a system consisting of purified cytochrome b558
and neutrophil or EBV-B lymphocyte cytosol con-
taining the cytosolic factors. With purified cy-
tochrome b from EBV-B lymphocytes and the558
cytosol from neutrophils, reconstituted oxidase dis-
y y1 played a turnover of 187 mol O s mol cy-2
.y1  .tochrome b Table 4 , a value similar to that558
obtained when reconstitution was performed with
purified cytochrome b and cytosol from neu-558
trophils. In the reconstitution experiment carried out
with purified cytochrome b obtained either from558
the B cells or from neutrophils, the use of lympho-
cyte cytosol instead of neutrophil cytosol resulted in
a decreased turnover value. This result is in accor-
w xdance with recent data 23 on the relative contents of
EBV-B lymphocyte cytosolic constituents and those
of neutrophils; they were reported as being approxi-
mately 50% and 20% for p47-phox and p67-phox,
respectively, suggesting that in EBV-B lymphocytes,
the oxidase activity was limited not only by the low
amount of cytochrome b 2% in B lymphocytes as558
.compared to neutrophils , but also by a limited cy-
tochrome b activation process, due to a deficit in558
the cytosolic activating factor concentration or in the
p47-phoxrp67-phox ratio. A similar observation was
w xrecently reported 49 , in which, because of an in-
complete cytosolic factor equipment absence of
.p47-phox , the oxidase turnover was measured to be
y y1 in the range of 60 mol O s mol cytochrome2
.y1b ; the turnover value increased to 153 after558
w xcomplementing with the missing factor 49 . The
results shown in Tables 4 and 5, obtained with lym-
phocyte oxidase components, suggest that, once cy-
tochrome b has been extracted from the mem-558
brane, its behaviour depends only on the concentra-
tion and the stoichiometry of cytosolic factors. More-
over, cytochrome b mRNA levels for gp91-phox558
in B cells have been reported as being comparable to
those found in myeloid cells, suggesting that in B
lymphocytes there is a post- transcriptional block of
w xaccumulation of the cytochrome protein 48 .
In conclusion, we have confirmed that cytochrome
b is the major limiting factor of the NADPH558
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oxidase activity measured in EBV-B lymphocytes
 .intact cells or membrane , after reconstitution. We
have shown that once cytochrome b has been558
isolated from the membrane environment, its be-
haviour is similar to that of neutrophil cytochrome
b , and that it depends only on the stoichiometry558
and concentration of the cytosolic activating factors.
The results suggest that the low NADPH oxidase
activity in EBV-B lymphocytes may result from a
defect in the activation process possibly inherent in
an unfavorable cytochrome b membrane environ-558
ment.
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